Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dependence01:17

Drug Dependence

1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

888
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
888
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Drug Elimination: Overview01:18

Drug Elimination: Overview

2.4K
Drug elimination involves many complex processes and does not necessarily differentiate between distribution and elimination. It is divided into two primary components: excretion and biotransformation.
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
2.4K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

294
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
294

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Systematic Review of International Guidelines for Addressing Alcohol Use Disorder in Pregnancy.

Alcohol, clinical & experimental research·2026
Same author

Fertility Beliefs and Menstrual Experiences Among Women Entering Opioid Use Disorder Treatment.

Journal of addiction medicine·2026
Same author

Atypical Antipsychotics to Manage Behavioral Symptoms in Autism Spectrum Disorder.

American family physician·2026
Same author

Cervical Cancer and Sexually Transmitted Infections Screening Among Individuals with a Substance Use Disorder: A Retrospective Cohort Study.

Population health management·2026
Same author

Narrowing differences in the rate of alcohol-related acute care admissions in the United States between women versus men, 2016-2023.

Alcohol, clinical & experimental research·2026
Same author

Patient Profiles of Buprenorphine Initiators in General Healthcare Settings: A Latent Class Approach.

Journal of general internal medicine·2026

Related Experiment Video

Updated: Jan 9, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

754

Practical guidance for navigating buprenorphine discontinuation.

Kento Sonoda1, Amanda B Hilmer2, Jennifer K Bello2

  • 1Department of Family and Community Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA. kento.sonoda@health.slu.edu.

Harm Reduction Journal
|December 5, 2025
PubMed
Summary
This summary is machine-generated.

Discontinuing buprenorphine requires understanding patient needs and risks. This commentary offers a practical guide for clinicians to support patients considering stopping this life-saving opioid use disorder medication.

Keywords:
BuprenorphineOpioid use disorderOverdose

More Related Videos

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.1K
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

2.9K

Related Experiment Videos

Last Updated: Jan 9, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

754
Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.1K
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

2.9K

Area of Science:

  • Addiction Medicine
  • Pharmacology
  • Public Health

Background:

  • Opioid use disorder affects millions, with high overdose mortality.
  • Buprenorphine significantly reduces morbidity and mortality.
  • Patient interest in discontinuing buprenorphine exists due to factors like stigma, despite its benefits.

Purpose of the Study:

  • To provide a practical approach for navigating buprenorphine discontinuation.
  • To highlight the importance of understanding patient-specific factors in the discontinuation process.

Main Methods:

  • The commentary utilizes two case studies to illustrate buprenorphine discontinuation.
  • It emphasizes a clinician's need for a deep understanding of the patient's substance use journey.

Main Results:

  • A personalized discontinuation plan should consider patient well-being, safety, and relapse risk.
  • Understanding internal and external factors driving the patient's decision is crucial.

Conclusions:

  • Buprenorphine is a vital, life-saving medication for opioid use disorder that can be continued long-term.
  • Clinicians should support patients through discontinuation by focusing on individualized care and reinforcing buprenorphine's role as a recovery tool.